Danieli Andrade

Long COVID: major findings, mechanisms and recommendations

Myeloid-derived suppressor cells coming of age

Shared and Distinct Functions of Type I and Type III Interferons

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

Clinical characteristics of antiphospholipid antibody syndrome in children

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases

The Pathogenesis of the Antiphospholipid Syndrome

The JAK/STAT signaling pathway: from bench to clinic

Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis

Cerebral Sinovenous Thrombosis in Children

Differentiation between severe HELLP syndrome and thrombotic microangiopathy, thrombotic thrombocytopenic purpura and other imitators

Humanized mice for immune system investigation: progress, promise and challenges

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Update on the Diagnosis, Treatment, and Prognosis of the Catastrophic Antiphospholipid Syndrome

14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome

Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of a series of 280 patients from the “CAPS Registry”

Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Update on the Catastrophic Antiphospholipid Syndrome and the “CAPS Registry”

Diagnosis and management of catastrophic antiphospholipid syndrome

Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing

Catastrophic Antiphospholipid Syndrome: Candidate Therapies for a Potentially Lethal Disease

Signatures of Mitochondrial Dysfunction and Impaired Fatty Acid Metabolism in Plasma of Patients with Post-Acute Sequelae of COVID-19 (PASC)

Influence of Resveratrol on the Immune Response

Insufficient interleukin‐12 signalling favours differentiation of human CD4⁺ and CD8⁺ T cells into GATA‐3⁺ and GATA‐3⁺ T‐bet⁺ subsets in humanized mice

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review

Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS

Arginase-1–dependent promotion of T _H 17 differentiation and disease progression by MDSCs in systemic lupus erythematosus

Hematological Problems in Pediatric Intensive Care

Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB‐RAG‐2^−/−IL‐2Rγ^−/− mice: A promising model for studying human disease

Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases

Brief Report: Induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab

14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends

Interferon‐α and Angiogenic Dysregulation in Pregnant Lupus Patients Who Develop Preeclampsia

Oxygen uptake kinetics and chronotropic responses to exercise are impaired in survivors of severe COVID-19

Update on antiphospholipid antibody syndrome